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several time points during aging, although a significant 
reduction in cortical bone was observed in RPTPμ-knock-
out/LacZ knock-in mice at 20 weeks. Changes in trabecu-
lar bone were more subtle. Our data show that RPTPμ is a 
new marker for osteocytes.
Keywords Osteocytes · RPTPμ · Bone · Micro-CT · 
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Introduction
Osteocytes are the most abundant cell type in bone and 
are involved in several processes in bone homeostasis and 
metabolism as extensively reviewed by Bonewald (2011). 
When osteoblasts become embedded in the newly syn-
thesized bone matrix, they develop dendritic processes, 
change shape and thus differentiate into osteocytes. Dur-
ing this process, osteocalcin levels are elevated (Mikuni-
Takagaki et al. 1995) and E11 is expressed (Wetterwald 
et al. 1996; Schulze et al. 1999) which may play a role in 
osteocyte morphology (Zhang et al. 2006). Osteocytes are 
involved in phosphate metabolism and matrix mineraliza-
tion through the proteins PHEX, MEPE, FGF23, BSP and 
DMP-1, which are all strongly expressed by osteocytes 
(reviewed in Atkins and Findlay 2012). The osteocyte-
derived protein sclerostin plays a key role in regulation of 
bone formation by modulating BMP and Wnt signaling 
(van Bezooijen et al. 2004; Ten Dijke et al. 2008; Moe-
ster et al. 2010). The position of the osteocytes within the 
mineralized matrix and the network of cellular processes 
make them very well positioned to act as “the nerve cells 
of the bone.” They have been shown to be sensitive to fluid 
flow shear stress (Klein-Nulend et al. 1995). Tatsumi et al. 
(2007) have reported that targeted ablation of osteocytes in 
Abstract Osteocytes are the predominant cells in bone, 
where they form a cellular network and display impor-
tant functions in bone homeostasis, phosphate metabolism 
and mechanical transduction. Several proteins strongly 
expressed by osteocytes are involved in these processes, 
e.g., sclerostin, DMP-1, PHEX, FGF23 and MEPE, while 
others are upregulated during differentiation of osteoblasts 
into osteocytes, e.g., osteocalcin and E11. The receptor-
type protein tyrosine phosphatase µ (RPTPμ) has been 
described to be expressed in cells which display a cel-
lular network, e.g., endothelial and neuronal cells, and is 
implied in mechanotransduction. In a capillary outgrowth 
assay using metatarsals derived from RPTPμ-knock-out/
LacZ knock-in mice, we observed that the capillary struc-
tures grown out of the metatarsals were stained blue, as 
expected. Surprisingly, cells within the metatarsal bone 
tissue were positive for LacZ activity as well, indicating 
that RPTPμ is also expressed by osteocytes. Subsequent 
histochemical analysis showed that within bone, RPTPμ 
is expressed exclusively in early-stage osteocytes. Analy-
sis of bone marrow cell cultures revealed that osteocytes 
are present in the nodules and an enzymatic assay enabled 
the quantification of the amount of osteocytes. No appar-
ent bone phenotype was observed when tibiae of RPTPμ-
knock-out/LacZ knock-in mice were analyzed by μCT at 
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mice induced bone loss with deterioration of bone architec-
ture. However, upon mechanical unloading, these mice did 
not show bone loss compared with control mice. In addi-
tion, the absence of connexin 43 in osteoblasts/osteocytes 
also protected against mechanical unloading, while increas-
ing the effect of mechanical loading (Lloyd et al. 2013; 
Bivi et al. 2013), implying an important role for osteocytes 
in mechanical induced bone homeostasis.
The receptor-like protein tyrosine phosphatase µ 
(RPTPµ) belongs to the MAM (meprin/A5/RPTPμ) con-
taining subfamily of transmembrane protein tyrosine phos-
phatases. RPTPµ is expressed in some types of neuronal 
cells, lung epithelium, cardiac muscle cells and distinct 
endothelial cells (Koop et al. 2003). An important com-
mon feature of these cell types is the importance of cell–
cell interactions. Strikingly, some of these cells also form 
a cellular network. RPTPµ is involved in cell–cell interac-
tions (Brady-Kalnay and Tonks 1994; Gebbink et al. 1995; 
Zondag et al. 1995) and may play a role in the formation 
or maintenance of the cellular network. Accordingly, little 
RPTPµ expression is found in fenestrated types of endothe-
lium, as present in the liver or the spleen (Bianchi et al. 
1999).
RPTPµ-knock-out/LacZ knock-in mice, in which the 
expression of the LacZ gene is controlled by the RPTPµ 
promoter, allow for the analysis of RPTPµ expression in 
vivo in various tissues (Koop et al. 2003). These mice were 
shown to have decreased flow-induced dilatation in mesen-
teric arteries, implying a role for RPTPµ in mechanotrans-
duction (Koop et al. 2005). To analyze the expression of 
RPTPμ in endothelial cells in an angiogenesis assay, we 
have performed capillary outgrowth assays using metatar-
sals derived from RPTPµ-knock-out/LacZ knock-in mice. 
To our surprise, not only the outgrowing capillaries were 
positive for LacZ, but also osteocytes within the metatar-
sal bone tissue showed LacZ expression. Here, we report 
that, in bone tissue, RPTPµ is expressed exclusively in the 
osteocytes and therefore is a new marker for osteocytes.
Materials and methods
Mice
Homozygous RPTPµ-knock-out/LacZ knock-in mice were 
obtained from Prof. W.H. Moolenaar (The Dutch Cancer 
Institute, Amsterdam, The Netherlands). These mice were 
generated by replacing exon 1 of the RPTPµ gene from the 
start codon to the splice donor site by the LacZ gene, as 
described by Koop et al. (2003). Wild-type FVB mice were 
obtained from Harlan (Horst, The Netherlands). Homozy-
gous RPTPµ-knock-out/LacZ knock-in were crossbred 
with wild-type FVB mice to generate heterozygous 
RPTPµ-knock-out/LacZ knock-in mice. Subsequently, 
these heterozygous RPTPµ-knock-out/LacZ knock-in mice 
were used to breed wild-type and knock-out littermates for 
μCT analysis of bone architecture.
Mice were kept in a controlled 12-h/12-h light/dark 
cycle and had unlimited access to food and water. All ani-
mal experiments were performed with approval of the Ethi-
cal Committee for animal experiments of the LUMC.
Immunohistochemistry and β‑galactosidase staining
RPTPμ-knock-out/LacZ knock-in mice were killed 
either by decapitation (5-day-old neonatal mice) or by 
cervical dislocation (adult mice). Long bones and cal-
variae were prepared and fixed in LacZ fixative (0.1 mM 
NaH2PO4(H2O)/2 mM MgCl2/5 mM EGTA/0.26 % glu-
taraldehyde) for 30 min. After washing the bones in 
LacZ washing buffer (0.1 mM NaH2PO4(H2O)/2 mM 
MgCl2/0.2 % Nonidet P 40/0.1 % deoxycholate) three 
times for 10 min, they were stained for β-galactosidase 
activity in LacZ staining solution (LacZ washing buffer 
supplemented with 1 mg/ml X-gal, 5 mM K3Fe(CN)6 and 
5 mM K4Fe(CN)6(3H2O)) overnight at room temperature. 
The long bones were postfixed in 3.7 % formaldehyde in 
PBS overnight at 4 °C, decalcified in 15 % EDTA/0.5 % 
paraformaldehyde for 2 weeks and embedded in paraffin. 
Sections (5 µm) were counterstained using the staining 
procedure for connective tissue according to Von Weichert-
Giesson. Images were acquired using a color CCD camera 
mounted on a Nikon Eclipse 610 microscope. The calvariae 
were postfixed as described, washed twice in PBS and pho-
tographed directly using a Contax 167MT camera mounted 
on a Zeiss microscope.
Cultures of metatarsals or bone marrow stromal cells 
were washed two times in PBS, fixed in LacZ fixative 
for 3 min, washed in LacZ washing buffer three times for 
5 min and stained for β-galactosidase activity in LacZ 
staining solution overnight at room temperature. Following 
postfixation in 3.7 % formaldehyde in PBS for 10 min, the 
cultures were washed twice with PBS and photographed.
PECAM-1 staining of metatarsal cultures was per-
formed as described (Deckers et al. 2001). Briefly, the 
cultures were fixed in zinc macrodex formalin fixative and 
incubated with ER-MP12 for 16 h at 4 °C. After incubation 
with a biotinylated secondary antibody, the signal was visu-
alized using the AEC chromogen.
Capillary outgrowth assay
Capillary outgrowth assays were performed essentially as 
described (Deckers et al. 2001). In brief, 17-day-old fetuses 
were isolated from pregnant RPTPμ-knock-out/LacZ 
knock-in mice, and metatarsals were dissected. Metatarsals 
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were allowed to attach for 72 h in 175 µl minimal essen-
tial medium alpha (α-MEM; Gibco, Carlsbad, CA, USA)/
penicillin/streptomycin (Gibco)/10 % (v/v) heat-inactivated 
fetal calf serum (FCS; Greiner Bio-One, Kemsmünster, 
Austria). After the attachment phase, medium was replaced 
with 250 µl fresh culture medium. Following 7 more days 
of culture, outgrowth of capillaries was visualized by stain-
ing for PECAM-1 or β-galactosidase activity as described 
above.
Bone marrow cell cultures
RPTPμ-knock-out/LacZ knock-in mice of 8 weeks old 
were killed by cervical dislocation. Both femurs and tibiae 
were isolated, the ends were removed, and the bone marrow 
was obtained by flushing with 5 ml 10 % FCS in PBS. For 
one differentiation assay, cells of 2–3 mice were pooled, 
seeded at a density of 1.5 × 106 cells/well in 12-well plates 
and cultured in phenol red-free α-MEM (Gibco) supple-
mented with 10 % (v/v) heat-inactivated FCS, penicillin/
streptomycin, and 50 µg/ml ascorbic acid (BDH Prolabo, 
VWR International, Radnor, PA, USA). The bone marrow 
cells were cultured for 21 days, and medium was refreshed 
every 3–4 days. From day 11 of culture onward, the cul-
tures were either supplemented with 10 mM β-glycerol 
phosphate (Sigma-Aldrich, St. Louis, MO, USA) alone or 
stimulated with BMP-4 (50 ng/ml; R&D systems, Minne-
apolis, MN, USA), BMP-6 (100 ng/ml; R&D systems) or 
Noggin (250 ng/µl; R&D systems) as well. At day 21, the 
culture medium was withdrawn and the cell layers were 
processed for β-galactosidase activity determination either 
by staining with X-gal or by an enzymatic assay using 
o-nitro-phenyl-β-D-galactopyranoside (ONPG; Sigma-
Aldrich). Parallel cultures were washed twice with PBS, 
fixed in 3.7 % formaldehyde in PBS for 5 min and stained 
with 2 % alizarin red S solution (Sigma-Aldrich).
Enzymatic assay for the quantification of β‑galactosidase 
activity in bone marrow cultures
Cell cultures were washed twice with PBS and lysed in 500 µl 
ALP lysis buffer (10 mM glycine/0.1 mM MgCl2/10 µM 
ZnCl2/0.1 % Triton X-100) overnight at 4 °C. Of this lysate, 
100 µl was added to 150 µl of LacZ assay buffer (0.1 M 
K2HPO4/0.1 % Triton X-100/0.02 M Na2HPO4/2.2 mM 
KCl/0.2 mM MgSO4/7 mM 2-mercaptoethanol) contain-
ing 1 mg/ml o-nitro-phenyl-β-D-galactopyranoside (ONPG) 
and incubated for 3 h at 37 °C. The amount of o-nitro-phe-
nol formed was determined by measuring the absorption of 
the assay solution at 405 nm using a ThermoMax micro-
plate reader (Molecular Devices, Sunnyvale, CA, USA). The 
β-galactosidase activity was corrected for the amount of DNA 
in the cultures. To release the DNA from the cell debris, the 
remaining cell lysate was incubated with an equal volume 
of SCC buffer containing 100 µg/ml proteinase K (Invitro-
gen, Carlsbad, CA, USA) for 40 h at 56 °C. DNA content 
was measured using Hoechst 33258 (ICN Biomedicals, Inc., 
Irvine, CA, USA) and calibrated against a DNA standard 
(0.5–10 µg/ml herring sperm DNA; Invitrogen).
Reverse‑transcribed polymerase chain reaction (RT‑PCR)
Total RNA was isolated from bone marrow cell cultures at 
five time points (days 7, 10, 14, 17 and 21) during differen-
tiation with Trizol LS reagent (Invitrogen). Subsequently, 
cDNA was synthesized using random primers and M-MLV 
reverse transcriptase (Promega, Madison, WI, USA) 
according to the manufacturer’s instructions. Expression 
of alkaline phosphatase, osteocalcin, LacZ and Sost was 
determined by quantitative RT-PCR using the QuantiTect 
SYBR Green PCR kit (Qiagen, Venlo, The Netherlands) 
with a CFX96 Touch Real-Time PCR Detection System 
(BioRad, Hercules, CA, USA). Primers (Eurogentec, Sera-
ing, Belgium) were designed using Primer Blast; sequences 
are given in Table 1. Measurements were performed in 
triplicate and analyzed using the 2−ΔΔCt method with 
β2-microglobulin as internal control (Pfaffl 2001).
Micro‑computed tomography
The left tibiae of 8-, 20-, 32-, 44- and 56-week-old RPTPμ-
knock-out/LacZ knock-in mice and wild-type littermates 
(n = 5–9 per genotype/age group) were prepared for 
micro-computed tomography (μCT) by fixing with 3.7 % 
Table 1  Primers used in quantitative RT-PCR for the analysis of gene expression during osteogenic differentiation of bone marrow-derived stem 
cells
Gene Forward primer Reverse primer
β2‑Microglobulin 5′-TGACCGGCTTGTATGCTATC-3′ 5′-CAGTGTGAGCCAGGATATAG-3′
Alkaline phosphatase 5′-ACACCACAACACGGGCGAGG-3′ 5′-TGCCCTCGTTGGCCTTCACG-3′
Osteocalcin 5′ -AGAGACAAGTCCCACACAGCAGC-3′ 5′ -TGAAGGCTTTGTCAGACTCAGGGC-3′
LacZ 5′-CTACGTCTGAACGTCGAAAACCCG-3′ 5′-GTAGCGGTCGCACAGCGTGTACCAC-3′
Sost 5′-TCCTCCTGAGAACAACCAGAC-3′ 5′-TGTCAGGAAGCGGGTGTAGTG-3′
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formaldehyde in PBS for 24 h at 4 °C and stored in 70 % 
alcohol. They were subsequently scanned using the SkyS-
can 1076 µCT scanner (SkyScan, Kontich, Belgium) with a 
source voltage of 40 kV and a current set to 250 µA, using 
a step size of 0.8° over a trajectory of 180°. Images were 
made with a voxel size of 9 µm and a frame averaging of 3 
to reduce noise. Beam hardening was reduced using a 1-mm 
aluminum filter. Reconstructions were made using NRecon 
software (version 1.6.2.0; SkyScan) with a ring artifact cor-
rection of 5 and a beam hardening correction set to 20 %. 
The proximal tibia (0.5–1.5 mm from the growth plate) was 
chosen as the region of interest to study trabecular and corti-
cal bone. To distinguish calcified tissue from non-calcified 
tissue, the reconstructed grayscale images were segmented 
by an automated algorithm using local thresholds (Waars-
ing et al. 2004). The trabeculae and cortex were separated 
using PrStackBot-New (software developed by the Ortho-
pedic Research Laboratory, Erasmus MC). The following 
three-dimensional (3D) bone morphometric parameters 
were determined using the freely available software package 
3D-Calculator (http://www.erasmusmc.nl/47460/386156/
Downloads): cortical volume (Ct.V; mm3), cortical thick-
ness (Ct.Th; µm), endocortical volume (Ec.V; mm3), struc-
ture model index (SMI), trabecular separation (Tb.Sp; µm), 
trabecular volume (Tb.V; mm3), trabecular thickness (Tb.
Th; µm) trabecular number (Tb.N; mm−1) and trabecular 
connectivity (Conn.). The SkyScan CT-Analyzer software 
was used to determine the following two-dimensional (2D) 
parameters: cortical area (Ct.Ar; mm2), mean polar moment 
of inertia (MMI(pol); mm4), cortical perimeter (Ct.Pm; mm) 
and endocortical perimeter (Ec.Pm; mm). Trabecular bone 
volume fraction (BV/TV; %) was calculated by dividing 
trabecular volume by endocortical volume, while trabecular 
connectivity density (Conn.D; mm−3) was derived by divid-
ing connectivity by endocortical volume.
Statistical analysis
Values represent mean ± SEM. Statistical analysis of the nor-
mally distributed data was performed with Graphpad Prism 
5 software (La Jolla, CA, USA) using one-way analysis of 
variance (ANOVA), followed by the post hoc Bonferroni test. 
For statistical analysis of µCT data, a Student’s t test was per-
formed. Results were considered significant at p < 0.05.
Results
RPTPµ expression in angiogenesis of metatarsal 
explants
To analyze the expression of RPTPµ in the capillary out-
growth of our angiogenesis assay, metatarsals from 
17-day-old RPTPμ-knock-out/LacZ knock-in fetuses were 
dissected, cultured for 10 days and stained for the endothe-
lial cell marker PECAM-1 (CD31) and β-galactosidase 
activity. During the culture period, a feeder layer of fibro-
blast-like cells had grown from the metatarsals on which 
PECAM-1-positive tube-like structures were formed 
(Fig. 1a). When stained for β-galactosidase activity, the 
capillary structures showed a deep blue color, demonstrat-
ing the expression of the RPTPµ gene in these endothelial 
cells (Fig. 1b). In addition, within the bone of the metatar-
sal, the osteocytes were stained blue (see Fig. 2b).
Expression of RPTPµ within bone
To examine the expression of RPTPµ within bone, calvariae, 
metatarsals and tibiae of 5-day-old neonatal and tibiae of 
adult RPTPμ-knock-out/LacZ knock-in mice were isolated 
Fig. 1  β-Galactosidase activity in capillary outgrowth of metatar-
sals. Cultures of metatarsals of 17-day-old RPTPμ-knock-out/LacZ 
knock-in fetuses were stained for the endothelial cell marker PECAM 
(CD31) (a) and LacZ (b). The capillary outgrowth shows a clear blue 
staining, illustrating the expression of RPTPµ in these cells. Bars rep-
resent 200 µm
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and analyzed for β-galactosidase activity by staining with 
X-gal. Within the neonatal calvariae, the osteocytes were 
stained for β-galactosidase activity and the cellular network 
was clearly visible (Fig. 2a). Blood vessels within sutures 
were also stained (data not shown). Histological sections of 
neonatal metatarsals and tibiae revealed that within the bone, 
the osteocytes exhibited β-galactosidase activity, while oste-
oblasts did not (Fig. 2b, c). In osteoclasts, no β-galactosidase 
activity was present (not shown). Adult tibiae showed the 
same expression pattern of RPTPµ. Only osteocytes dis-
played β-galactosidase activity in contrast to lining cells 
(Fig. 2d). The blue staining was present throughout the cells, 
and the cellular processes could be easily distinguished.
Osteocytes are generated in vitro
Under osteogenic culture conditions, murine bone mar-
row stromal cells (MSCs) are able to form nodules in 
culture. However, it is not known whether within these 
nodules osteoblasts differentiate into osteocytes. To 
examine the presence of osteocytes within these nod-
ules, MSCs from RPTPμ-knock-out/LacZ knock-in mice 
were cultured under osteogenic conditions for 21 days 
with or without the presence of BMPs. After staining 
for β-galactosidase activity, positive cells were observed 
within the cultures (Fig. 3a). Addition of BMPs to the 
culture medium increased the number of blue-stained 
cells (Fig. 3b). Close observation showed blue-stained 
cells within the calcified nodules, but the majority of 
the blue-stained cells were observed next to the calci-
fied areas. Sections of the cell layers of the differenti-
ated MSC cultures stained with X-gal demonstrated that 
only cells embedded in matrix show LacZ expression 
(Fig. 3c). At larger magnification, some of these blue-
stained cells showed cellular processes, a characteristic 
of osteocytes in vivo (Fig. 3d).
Fig. 2  Expression of RPTPµ in bone. Calvariae (a), metatarsals (b) 
and tibiae (c) of 5-day-old neonatal and tibiae (d) of adult RPTPμ-
knock-out/LacZ knock-in mice were stained for β-galactosidase 
activity using X-gal. Within the calvariae, the cellular network of 
osteocytes is stained blue. In neonatal metatarsals and tibiae, the 
osteocytes (arrows) show a deep blue color, while the osteoblasts 
(arrowheads) are not stained. The adult tibiae also show that the blue 
staining representing RPTPµ expression is only present in osteocytes 
(arrows), while lining cells (arrowheads) are negative. The cellu-
lar processes (cp) are clearly visible. Bars: a 50 µm; b 100 µm; c, d 
25 µm
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BMPs stimulate osteocyte formation in vitro
When the MSC cultures were stained for β-galactosidase 
activity, blue cells could be observed within the nodules. 
However, these cells were difficult to observe and quan-
tify since they are embedded within the (calcified) matrix 
(Fig. 3). To quantify the amount of osteocytes formed within 
the cultures, we used an enzymatic LacZ assay, in which 
the yellow o-nitro-phenol is hydrolyzed from the substrate 
o-nitro-phenyl-β-D-galactopyranoside by β-galactosidase. 
MSCs were cultured for 21 days with or without BMPs 
or Noggin and analyzed for β-galactosidase activity. In 
the presence of BMP-6, a twofold to fourfold increase in 
β-galactosidase activity could be observed (Fig. 4a). BMP-4 
also increased β-galactosidase activity, but to a lesser extent 
(1.5–2 fold). Noggin strongly inhibited the formation of 
bone nodules and therefore also osteocytes, which coincided 
with a reduction of β-galactosidase activity to approximately 
20 %. Mineralization of the cultures was increased by BMPs 
and decreased by Noggin, as can be observed from the aliza-
rin red S staining, though to a lesser extent (Fig. 4b, c).
Expression of osteoblast and osteocyte markers
The expression of osteoblast (alkaline phosphatase, 
osteocalcin) and osteocyte (LacZ, Sost) markers in the 
MSC cultures over time was analyzed by quantitative 
RT-PCR. Expression was normalized to the expression 
of the housekeeping gene β2-microglobulin, and rela-
tive expression to day 7 (day 14 for Sost) was calculated 
using the 2−ΔΔCt method. Within the MCS cultures, alka-
line phosphatase (Fig. 5a), osteocalcin (Fig. 5b), LacZ 
(Fig. 5c) and Sost (Fig. 5d) expression increased dur-
ing differentiation. Alkaline phosphatase, osteocalcin 
and LacZ are present from day 7; sclerostin is expressed 
from day 14 onwards. While LacZ reached a maximum 
expression at day 17, Sost expression was the highest at 
day 21. Since LacZ expression is restricted to osteocytes 
as is the Sost gene, the expression of LacZ should coin-
cide with the expression of Sost. However, these results 
indicate that RPTPμ expression, represented by LacZ 
in these MSCs, occurs earlier in osteocyte development 
than sclerostin.
Fig. 3  Osteocytes can be generated in vitro. Bone marrow stro-
mal cells (MSC) of RPTPμ-knock-out/LacZ knock-in mice were 
cultured for 21 days under osteogenic conditions and stained for 
β-galactosidase activity using X-gal. Within the cultures, blue-stained 
cells can be observed (a). The number of blue-stained cells is mark-
edly increased when BMPs were added to the medium (b). Close 
observation shows that within the mineralized (M) nodules osteocytes 
are present, although the number of blue-stained cells is higher in the 
non-mineralized areas of the nodules. Histological analysis of the 
MSC cultures shows that only cells that are embedded within matrix 
show β-galactosidase activity (c). Some of these cells show cellular 
processes, which is very characteristic for osteocytes, which can be 
observed in a larger magnification of the same area (arrowheads d). 
Bars a, b 250 µm; c, d 25 µm
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Effects of RPTPµ deficiency on bone micro‑architecture 
at several stages of development
We performed ex vivo micro-CT on the left tibiae of female 
RPTPμ-knock-out/LacZ knock-in mice and their WT litter-
mates at the age of 8, 20, 32, 44 and 56 weeks to determine 
the effect of RPTPµ deficiency on both cortical and trabecu-
lar bone micro-architecture. At sacrifice, total body weight 
was determined and showed no significant differences 
between WT and RPTPμ-knock-out/LacZ knock-in mice 
(data not shown). No significant differences in bone micro-
architecture between WT and RPTPμ-knock-out/LacZ 
knock-in mice were observed at any age except at 20 weeks.
Cortical bone mass was lower in 20-week-old RPTPμ-
knock-out/LacZ knock-in mice as exemplified by lower 
cortical area (p < 0.05 vs. WT, Fig. 6a) and cortical volume 
(0.374 ± 0.011 mm3 vs. 0.407 ± 0.006 mm3, p < 0.05 vs. 
WT). Figure 6 also shows cortical thickness (b) and cortical 
perimeter (c), which had a tendency to be lower in RPTPμ-
knock-out/LacZ knock-in mice, but these differences did 
not reach statistical significance (p = 0.14 and p = 0.08 
vs. WT, respectively). Altogether these results show that 
tibiae of RPTPμ-knock-out/LacZ knock-in mice did not 
significantly differ in size from tibiae of WT mice, but did 
contain less cortical bone, suggesting that they have lower 
bone strength. This was supported by a significantly lower 
mean polar moment of inertia, which is a proxy for cortical 
bone strength (0.558 ± 0.030 mm4 vs. 0.644 ± 0.015 mm4, 
p < 0.05 vs. WT).
Besides these clear effects on cortical bone at 20 weeks, 
we also detected more subtle changes in trabecular bone of 
RPTPμ-knock-out/LacZ knock-in mice compared with WT 
mice at this age. Trabecular bone volume fraction tended 
to be lower in RPTPμ-knock-out/LacZ knock-in mice 
(p = 0.08 vs. WT, Fig. 6d), which is certainly not caused 
by changes in trabecular thickness (p = 0.53, Fig. 6e), but 
more likely by decreased connectivity density (p < 0.05 
vs. WT, Fig. 6f), indicating a lower degree of interconnec-
tion within the trabecular network. This may be explained 
by a combination of factors, namely less trabeculae that 
appear more rod-like in shape and are further shaped 
apart, as shown by trends toward lower trabecular number 
(1.54 ± 0.14 mm−1 vs. 1.88 ± 0.15, p = 0.14 vs. WT), 
increased structure model index (0.129 ± 0.016 mm−1 
vs. 1.876 ± 0.146 mm−1, p = 0.08 vs. WT) and increased 
trabecular separation (166 ± 10 µm vs. 141 ± 11 µm, 
p = 0.11 vs. WT).
Discussion
In the present study, we show that within bone tissue, 
RPTPµ is exclusively expressed in osteocytes and that 
osteocytes are formed within the bone nodules of MSC 
cultures, which can be visualized by light microscopy and 
quantified by an enzymatic assay. Staining of osteocytes 
for β-galactosidase activity illustrates that early-stage 
osteocytes express LacZ, in contrast to the osteocyte-spe-
cific protein sclerostin, which is only present in mineral-
ized osteocytes (Poole et al. 2005). Sclerostin, the pro-
tein of the Sost gene, is an osteocyte-specific inhibitor of 
bone formation (van Bezooijen et al. 2004), which when 
absent results in the sclerosing bone disorder sclerosteosis 
Fig. 4  BMPs stimulate, while Noggin inhibits the differentiation 
of osteocytes. Bone marrow stromal cells (MCS) of RPTPμ-knock-
out/LacZ knock-in mice were cultured under osteogenic condi-
tions for 21 days. Thereafter, the cell cultures were processed for 
β-galactosidase activity analysis by a LacZ enzymatic assay (a) or 
X-gal staining (b, c). Mineralization of the cultures was examined by 
alizarin red S staining (b, c). The enzymatic assay shows that BMP-6 
clearly stimulates, while Noggin inhibits osteocyte formation. Stain-
ing of the cultures with X-gal confirms this observation. The wells 
stimulated with BMP-6 show more blue staining than the control 
wells; the wells cultured in the presence of Noggin show hardly any 
blue staining (b). The same observation can be made from the larger 
magnification of the wells (c). Alizarin red S staining is also stimu-
lated by BMP-6 and reduced by Noggin, but to a lesser extend (b, c). 
Bars 200 µm; **p < 0.01; *** p < 0.001
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(Balemans et al. 2001; Brunkow et al. 2001). The Sost gene 
is expressed from day 14 in MSC cultures and from day 11 
in the murine osteoprogenitor cell line KS483 (van Bezoo-
ijen et al. 2004). DMP-1 is an extracellular matrix protein 
present in osteocytes in adults (Toyosawa et al. 2001). 
Kalajzic et al. (2004) have shown that in MSC cultures of 
transgenic mice expressing the green fluorescent protein 
(GFP) under control of the DMP-1 promoter, within the 
nodules osteocytes are present from day 13 onwards. Our 
data on LacZ expression concur with these results. How-
ever, since in RPTPμ-knock-out/LacZ knock-in mice the 
LacZ gene is expressed by knock-in, the formation of oste-
ocytes within cell cultures can be quantified. This provides 
an excellent tool for the study of compounds on osteocyte 
differentiation in vitro.
Interestingly, membrane-associated tyrosine phos-
phatases have been identified in rat osteosarcoma cells 
(Southey et al. 1995; Lezcano et al. 2014).
RPTPµ plays a role in cell–cell interaction and there-
fore is expressed in cell types in which this interaction is 
very important, e.g., osteocytes, endothelium, nerve cells 
and cardiac muscle cells. Within endothelium, expression 
varies and is increased with increasing cell–cell interac-
tions (Koop et al. 2003). In fenestrated endothelium, which 
is present in the liver, spleen and bone marrow, expression 
of RPTPµ is very low (Bianchi et al. 1999). In the brain, 
RPTPμ has been shown to be involved in axon guidance 
and neurite outgrowth (reviewed by Johnson and Van Vac-
tor (2003); Ensslen-Craig and Brady-Kalnay (2004)). We 
have shown that RPTPμ is expressed in early osteocytes. 
These osteoid osteocytes are developing the cellular pro-
cesses which form the cellular network. RPTPμ might be 
involved in the process, although the absence of RPTPμ 
does not prevent the processes from developing.
Osteocytes form a three-dimensional network within the 
mineralized matrix of the bone. This network is important 
for the supply of oxygen and nourishment to the osteo-
cytes. However, cell–cell interactions may also play a role 
in the signaling of mechanical loading of osteocytes to the 
cells on the surface of the bone. In RPTPµ-deficient mice, 
Koop et al. (2005) have shown that RPTPµ is involved in 
the mechanotransduction or accessory signaling pathway 
Fig. 5  Expression of osteoblast 
and osteocyte markers. RNA 
was isolated from RPTPμ-
knock-out/LacZ knock-in 
MSC cultures at days 7, 10, 
14, 17 and 21 of differentia-
tion. Expression of osteoblast 
[alkaline phosphatase (a) and 
osteocalcin (b)] and osteocyte 
[LacZ (c) and Sost (d)] markers 
was analyzed by quantitative 
RT-PCR with the housekeeping 
gene β2-microglobulin as inter-
nal control. Measurements were 
performed in triplo, and results 
are shown as expression relative 
to day 7 (a–c) or day 14 (d), the 
first day that expression could 
be shown, calculated using the 
2−ΔΔCt method. ***p < 0.001 
compared with day 7 (a–c) or 
day 14 (d)
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that controls shear stress responses in mesenteric resistance 
arteries. It has been shown that fluid flow shear stress plays 
an important role in osteocyte mechanotransduction (Klein-
Nulend et al. 1995; Fritton and Weinbaum 2009; Price et al. 
2011); therefore, RPTPµ might have a similar function in 
osteocytes.
Giepmans et al. (2003) showed that RPTPµ can bind 
directly to connexin-43, while Lezcano et al. (2014) have 
shown that bisphosphonates can decrease this association in 
ROS17/2.8 osteosarcoma-derived osteoblasts. Connexin-43 
is present in osteocytes, where they form gap junctions 
and hemichannels. Connexin-43 hemichannels are mecha-
nosensory in nature as they open when subjected to fluid 
flow shear stress, resulting in the magnitude-dependent 
release of PGE2 that is involved in bone remodeling 
(Siller-Jackson et al. 2008). The absence of connexin-43 in 
osteoblasts/osteocytes protected against unloading, while 
increasing the effect of mechanical loading (Lloyd et al. 
2013; Bivi et al. 2013).
Since connexin-43 hemichannels seem to play a crucial 
role in fluid flow shear stress-induced mechanotransduc-
tion, plus the fact that RPTPµ can directly bind to these 
hemichannels, it is tempting to suggest that RPTPµ is also 
involved in osteocyte mechanotransduction. Further studies 
are needed to investigate this.
Osteocytes depend on cell–cell interactions with other 
osteocytes and osteoblasts on the surface of the bone for 
nutrients and oxygen. In cortical bone, it is likely that 
cell–cell interactions play a larger role than in trabecu-
lar bone, since the distances to the surface of the bone are 
larger in osteons in cortical bone than in trabecular bone. 
This might explain why we have observed a clear reduc-
tion in cortical bone area and cortical volume using μCT 
analysis and more subtle differences in trabecular bone, 
becoming apparent at the age of 20 weeks. However, later 
in development the differences disappeared, suggesting that 
RPTPµ plays a major role around the age of 20 weeks, an 
important period in the development of the skeleton. These 
Fig. 6  Analysis of bone micro-architecture by ex vivo µCT. Bone 
micro-architecture of RPTPμ-knock-out/LacZ knock-in mice and 
wild-type FVB mice was analyzed by scanning tibiae of 8-, 20-, 
32-, 44- and 56-week-old mice (n = 5–9 per genotype/age group) 
with a SkyScan 1076 X-ray microtomograph. RPTPμ-knock-out/
LacZ knock-in mice show a significantly lower cortical area (a) at 
20 weeks in the proximal tibia compared with wild-type mice. Corti-
cal thickness (b) was unaltered and cortical perimeter (c) was slightly 
lower in RPTPμ-knock-out/LacZ knock-in mice, although this differ-
ence was not significant (p = 0.08). RPTPμ-knock-out/LacZ knock-
in mice show a slightly lower trabecular bone volume at 20 weeks 
(d), although this difference was not significant (p = 0.08). Trabecu-
lar thickness (e) was unaltered and trabecular connectivity density (f) 
was significantly lower in RPTPμ-knock-out/LacZ knock-in mice. 
*p < 0.05
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results were confirmed by BMD analysis using a PIXImus 
densitometer, which showed a lower, not significant, BMD 
in the femur of RPTPμ-knock-out/LacZ knock-in mice 
compared with WT littermates, but no differences in the 
lumbar spine (data not shown). Although we have observed 
these differences, no other apparent bone phenotype is pre-
sent in the RPTPμ-knock-out/LacZ knock-in mice. Since 
RPTPμ belongs to a large family of proteins, the effect of 
deletion of one of its members may be compensated by 
another family member.
Future research of the histological and biological prop-
erties of bone of RPTPμ-knock-out/LacZ knock-in mice 
might provide more information on the importance of this 
gene in osteocytes. Information about osteocyte function 
might provide therapeutic tools for intervention in dis-
eases in which the balance between bone formation and 
bone resorption is disturbed, e.g., osteoporosis. In addition, 
RPTPµ itself may be a target for therapy in bone disorders.
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